文档介绍：Costing report Kidney disease: peritoneal dialysis Implementing NICE guidance NICE clinical guideline 125 July 2011 National costing report: Kidney disease – peritoneal dialysis (July 2011) page 2 of 23 This costing report panies the clinical guideline: ‘Kidney disease: peritoneal dialysis in the treatment of stage 5 chronic kidney disease’(available online at /guidance/CG125). Issue date: July 2011 This guidance is written in the following context This report represents the view of the Institute, which was arrived at after careful consideration of the available data and through consulting healthcare professionals. It should be read in conjunction with the NICE guideline. The report and templates are implementation tools and focus on those areas that were considered to have significant impact on resource utilisation. The cost and activity assessments in the reports are estimates based on a number of assumptions. They provide an indication of the likely impact of the principal mendations and are not absolute figures. Assumptions used in the report are based on assessment of the national average. Local practice may be different from this, and the template can be amended to reflect local practice to estimate local impact. National Institute for Health and Clinical ExcellenceMidCity Place 71 High Holborn London WC1V 6NA ? National Institute for Health and Clinical Excellence, July 2011. All rights reserved. This material may be freely reproduced for educational and not-for-profit purposes. No reproduction by or anisations, or mercial purposes, is allowed without the express written permission of the costing report: Kidney disease – peritoneal dialysis (July 2011) page 3 of 23 Contents Executive summary .......................................................................................... 4Supporting implementation ...................................................................... 4Significant resource-impact mendations ....................